NATCO PHARMA LTD. - 524816 - Intimation Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
Intimation under Regulation 30 of SEBI (LODR) Regulations, 201507-12-2023
07-12-2023
Natco Pharma Share Price Live blog for 07 Dec 2023
Natco Pharma stock price went up today, 07 Dec 2023, by 0.76 %. The stock closed at 780.35 per share. The stock is currently trading at 786.3 per share. Investors should monitor Natco Pharma stock price closely in the coming days and weeks to see how it reacts to the news.07-12-2023
NATCO PHARMA LTD. - 524816 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for NDL Infra Tech Pvt Ltd04-12-2023
Natco Pharma Share Price Live blog for 04 Dec 2023
Natco Pharma stock price went down today, 04 Dec 2023, by -0.78 %. The stock closed at 792.1 per share. The stock is currently trading at 785.95 per share. Investors should monitor Natco Pharma stock price closely in the coming days and weeks to see how it reacts to the news.04-12-2023
Natco Pharma Share Price Live blog for 28 Nov 2023
Natco Pharma stock price went down today, 28 Nov 2023, by -1.17 %. The stock closed at 789.4 per share. The stock is currently trading at 780.2 per share. Investors should monitor Natco Pharma stock price closely in the coming days and weeks to see how it reacts to the news.28-11-2023
NATCO PHARMA LTD. - 524816 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Investor(s) meet on 28th and 29th November 2023 arranged by M/s. Investec at Mumbai25-11-2023
NATCO PHARMA LTD. - 524816 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
loss of share certificate24-11-2023
Natco Pharma Share Price Live blog for 23 Nov 2023
Natco Pharma stock price went down today, 23 Nov 2023, by -0.33 %. The stock closed at 799.5 per share. The stock is currently trading at 796.9 per share. Investors should monitor Natco Pharma stock price closely in the coming days and weeks to see how it reacts to the news.23-11-2023
USFDA observations: Mitigation plan in place, says Natco Pharma
Natco Pharma foresees minimal impact from USFDA observations on Kothur plant22-11-2023
NATCO PHARMA LTD. - 524816 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Transcript for the Q2FY24 Concall21-11-2023